Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sam Schulman

Showing results (91-100 of 308) with videos related to

Pageof 31
Sort By:
The Canadian Journal of Hospital Pharmacy|January 27, 2017
Appropriateness of Apixaban Dosing to Prevent Stroke in Patients with Atrial Fibrillation: A Pilot StudyStephanie Carlin, Jennifer Pickering, Sam Schulman
Thrombosis and Haemostasis|October 25, 2020
Venous Thromboembolism in COVID-19Sam Schulman, Yu Hu, Stavros Konstantinides
The Hematology Journal : the Official Journal of the European Haematology Association|January 11, 2003
Experiences of a low-intensity anticoagulation regimen for extended secondary prevention of venous thromboembolismPer Svensson, Anna Södermark, Sam Schulman
Thrombosis and Haemostasis|April 4, 2023
Anticoagulant Management and Outcomes in Nontraumatic Intracranial Hemorrhage Complicated by Venous Thromboembolism: A Retrospective Chart ReviewJohnathon Gorman, Matteo Candeloro, Sam Schulman
Thrombosis and Haemostasis|June 9, 2017
Venous thromboembolism: Past, present and futureSam Schulman, Walter Ageno, Stavros V Konstantinides
Regional Anesthesia and Pain Medicine|February 17, 2016
Periprocedural Management of Direct Oral Anticoagulants: Comment on the 2015 American Society of Regional Anesthesia and Pain Medicine GuidelinesJames D Douketis, Summer Syed, Sam Schulman
JAMA Internal Medicine|February 4, 2020
Epidural Catheter Use and Further Issues in Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant-ReplyAlex C Spyropoulos, Sam Schulman, James D Douketis
Thrombosis Journal|October 18, 2008
Clinical factors influencing normalization of prothrombin time after stopping warfarin: a retrospective cohort studySam Schulman, Rajae Elbazi, Michelle Zondag, et al.
Thrombosis Research|November 2, 2017
Optimal timing of starting thromboprophylaxis for patients with acute spinal cord injury: A survey of Canadian spine surgeonsSiavash Piran, Drew Bednar, Brian Drew, et al.
Journal of Thrombosis and Thrombolysis|November 25, 2017
Oral anticoagulant dosing, administration, and storage: a cross-sectional survey of Canadian health care providersSiavash Piran, Sam Schulman, Mohamed Panju, et al.
Pageof 31

Showing results (91-100 of 308) with videos related to

Sort By:
Pageof 31
The Canadian Journal of Hospital Pharmacy|January 27, 2017
Appropriateness of Apixaban Dosing to Prevent Stroke in Patients with Atrial Fibrillation: A Pilot StudyStephanie Carlin, Jennifer Pickering, Sam Schulman
Thrombosis and Haemostasis|October 25, 2020
Venous Thromboembolism in COVID-19Sam Schulman, Yu Hu, Stavros Konstantinides
The Hematology Journal : the Official Journal of the European Haematology Association|January 11, 2003
Experiences of a low-intensity anticoagulation regimen for extended secondary prevention of venous thromboembolismPer Svensson, Anna Södermark, Sam Schulman
Thrombosis and Haemostasis|April 4, 2023
Anticoagulant Management and Outcomes in Nontraumatic Intracranial Hemorrhage Complicated by Venous Thromboembolism: A Retrospective Chart ReviewJohnathon Gorman, Matteo Candeloro, Sam Schulman
Thrombosis and Haemostasis|June 9, 2017
Venous thromboembolism: Past, present and futureSam Schulman, Walter Ageno, Stavros V Konstantinides
Regional Anesthesia and Pain Medicine|February 17, 2016
Periprocedural Management of Direct Oral Anticoagulants: Comment on the 2015 American Society of Regional Anesthesia and Pain Medicine GuidelinesJames D Douketis, Summer Syed, Sam Schulman
JAMA Internal Medicine|February 4, 2020
Epidural Catheter Use and Further Issues in Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant-ReplyAlex C Spyropoulos, Sam Schulman, James D Douketis
Thrombosis Journal|October 18, 2008
Clinical factors influencing normalization of prothrombin time after stopping warfarin: a retrospective cohort studySam Schulman, Rajae Elbazi, Michelle Zondag, et al.
Thrombosis Research|November 2, 2017
Optimal timing of starting thromboprophylaxis for patients with acute spinal cord injury: A survey of Canadian spine surgeonsSiavash Piran, Drew Bednar, Brian Drew, et al.
Journal of Thrombosis and Thrombolysis|November 25, 2017
Oral anticoagulant dosing, administration, and storage: a cross-sectional survey of Canadian health care providersSiavash Piran, Sam Schulman, Mohamed Panju, et al.
Pageof 31